Pharmaceuticals
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. 
Subscribe to this data using MyMedWorm.
Subscribe to this data using GoogleReader.
Subscribe to this data using Bloglines.
Subscribe to this data using MyYahoo.
Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.
This page shows you the most recent publications within this specialty of the MedWorm directory. This is page number 30.
Boehringer Ingelheim Animal Health closes deal to acquire Animal Health Business from Pfizer
Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Boehringer Ingelheim, a global pharmaceutical group of companies, together with its U.S. animal health business Boehringer Ingelheim Vetmedica, Inc., has closed its deal with Pfizer to acquire a significant portion of the Fort Dodge Animal Health business.
Source: World Pharma News - October 28, 2009 Category: Pharmaceuticals Source Type: news
Hefty Side Effect For Kids On AntipsychoticsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Study finds troubling weight gains in children taking brand-name psychiatric drugs.
Source: Forbes.com Healthcare News - October 27, 2009 Category: Pharmaceuticals Source Type: news
Vertiyo Creative Group Announces Vertiyo Health, New Unit Focused on Pharmaceutical MarketingEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
NEW YORK--(BUSINESS WIRE)--Oct 27, 2009 -
Vertiyo Creative Group Inc., a full-service branding and
marketing agency based in New York City, today announced the launch
of Vertiyo Health, a new division focused on pharmaceutical
marketing. Vertiyo...
Source: Drugs.com - Pharma News - October 27, 2009 Category: Pharmaceuticals Source Type: news
Logical Therapeutics Announces Positive Results of LT-NS001 vs. Naproxen Clinical StudyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Bio-activated Prodrug Demonstrates Significant Reduction
in Incidence of GI Ulcers and Erosions
SAN DIEGO - October 27, 2009 - Logical Therapeutics, Inc., a
Waltham, MA-based biopharmaceutical company announced today the
positive results of a...
Source: Drugs.com - Clinical Trials - October 27, 2009 Category: Pharmaceuticals Source Type: clinical trials
European Medicines Agency to Review PML Cases With Natalizumab, Now at 24Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The EMEA has said it will begin a review of the risks and benefits of natalizumab and confirmed that cases of PML have now risen to 24 worldwide; 13 cases was the last reported count in September. Medscape Medical News
Source: Medscape Business of Medicine Headlines - October 27, 2009 Category: Pharmaceuticals Tags: Neurology & Neurosurgery Source Type: info
Antipsychotics Cause Weight Gain in KidsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Antipsychotic drugs widely used in children caused youths to gain as much as 19 pounds on average after just 11 weeks on the medications, according to a new study published in the Journal of the American Medical Association.
Source: WSJ.com: Health - October 27, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Reviving TysabriEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The drug's inventor believes a new test might identify people who are less at risk for a deadly side effect.
Source: Forbes.com Healthcare News - October 27, 2009 Category: Pharmaceuticals Source Type: news
ImmunoCellular Therapeutics Presents Data from Phase I Trial of ICT-107 Demonstrating Significant Increase in Tumor-Free Progression in Patients with Brain CancerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Data Presented at Congress of Neurological Surgeons Annual
Meeting Shows ICT-107 Extends Progression-Free Survival Time in
Glioblastoma Patients By More Than One Year
Company to Discuss Results in Conference Call Today at 11
a.m. Eastern...
Source: Drugs.com - Clinical Trials - October 27, 2009 Category: Pharmaceuticals Source Type: clinical trials
Lieberman Opposes Health BillEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Sen. Joe Lieberman said he would vote to block passage of Senate health-care language in its current form, dealing a setback to efforts to gather 60 votes for the bill.
Source: WSJ.com: Health - October 27, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
PolyMedix Completes Successful Phase 1B Clinical Study of Heparin Antagonist PMX-60056Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
PMX-60056 Heptagonist Meets Safety and Efficacy Endpoints
in Reversing Effects of Heparin
RADNOR, Pa.--(BUSINESS WIRE)--Oct 27, 2009 - PolyMedix, Inc.
(OTC BB: PYMX,
http://polymedix.com), an emerging biotechnology company
developing new...
Source: Drugs.com - Clinical Trials - October 27, 2009 Category: Pharmaceuticals Source Type: clinical trials
Results of Phase I Study Show Novel, Investigational PA65020 Compound Significantly Decreased Risk of Upper GI Damage in Healthy AdultsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Study Receives a Presidential Award from ACG
CHAPEL HILL, N.C.--(BUSINESS WIRE)--Oct 27, 2009 - POZEN Inc.
(NASDAQ: POZN) announced today the results of a Phase I study that
showed a novel, investigational combination of...
Source: Drugs.com - Clinical Trials - October 27, 2009 Category: Pharmaceuticals Source Type: clinical trials
Merit Medical Systems Announces Three-Part Deal With Vysera Biomedical LimitedEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
SOUTH JORDAN, Utah, Oct. 27, 2009 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and gastroenterology procedures, announced today that the Company has completed a three-part deal with Vysera Biomedical Limited located in Galway, Ireland, which will give Merit access to certain intellectual property and know-how for valve technology, opportunities to commercialize certain biomaterial technology and equity ownership in Vysera.
Source: Medical News (via PRIMEZONE) - October 27, 2009 Category: Pharmaceuticals Source Type: news
Merit Medical Announces Record Sales, Up 15%, and Record Earnings, Up 17%, for the Third Quarter Ended September 30, 2009Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
SOUTH JORDAN, UTAH, Oct. 27, 2009 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and gastroenterology, today announced record revenues of $66.8 million for the quarter ended September 30, 2009, an increase of 15% over revenues of $58.2 million for the third quarter of 2008. Revenues for the nine-month period ended September 30, 2009 were a record $190.0 million, compared with $169.1 million for the comparable nine-month period in 2008, a gain of 12%.
Source: Medical News (via PRIMEZONE) - October 27, 2009 Category: Pharmaceuticals Source Type: news
GOP Targets AARP Insurance TiesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Republicans are taking aim at AARP's financial ties to the insurance industry as the advocacy group take a prominent role in support of health-care bill.
Source: WSJ.com: Health - October 27, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Isotechnika Pharma Announces Voclosporin Presentations at American Academy of OphthalmologyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
-- Partner Lux Biosciences Preparing to File for US and European
Approvals --
EDMONTON, Oct. 27 /CNW/ - Isotechnika Pharma Inc. (TSX:ISA)
today announced that results of the international Phase 2/3
clinical trials studying voclosporin,...
Source: Drugs.com - Clinical Trials - October 27, 2009 Category: Pharmaceuticals Source Type: clinical trials
Phase 2 Data From Oral NKTR-118 Presented at American College of Gastroenterology in San DiegoEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
New Approach to Treat Opioid-Induced Constipation
SAN DIEGO, Oct. 27 /PRNewswire-FirstCall/ -- Data from a phase
II study demonstrated that oral NKTR-118 improved lower
gastrointestinal dysfunction by increasing the frequency of bowel
movements...
Source: Drugs.com - Clinical Trials - October 27, 2009 Category: Pharmaceuticals Source Type: clinical trials
Orexigen Therapeutics Releases New Efficacy Data for Contrave(R) in Late Breaker Presentations at the 27th Annual Scientific Meeting of The Obesity SocietyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
SAN DIEGO, October 27, 2009 /PRNewswire-FirstCall/ --
Orexigen(R) Therapeutics, Inc. today announced results from new
intent to treat (ITT) analyses from the COR-I and COR-II Phase 3
trials of Contrave(R) (naltrexone SR/bupropion SR), the first...
Source: Drugs.com - Clinical Trials - October 27, 2009 Category: Pharmaceuticals Source Type: clinical trials
New Data From Arena Pharmaceuticals' Pivotal BLOSSOM Trial of Lorcaserin Demonstrate Improvements in Patients' Body Composition, Cardiovascular Risk Factors and Quality of LifeEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Late-Breaking Data Presented at the 27th Annual
Scientific Meeting of The Obesity Society Expand on Previously
Announced Highly Significant Top-Line Weight Loss Results
-
WASHINGTON, Oct. 27, 2009 /PRNewswire-FirstCall/ --...
Source: Drugs.com - Clinical Trials - October 27, 2009 Category: Pharmaceuticals Source Type: clinical trials
Vertiyo Creative Services Launches Pharma DivisionEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
NEW YORK (October 27, 2009) – Vertiyo Creative
Group<http://www.vertiyo.com/> Inc., a
full-service branding and marketing agency based in New York City,
today announced the launch of Vertiyo Health, a new division
focused on...
Source: Drugs.com - Pharma News - October 27, 2009 Category: Pharmaceuticals Source Type: news
No shortage of rabies vaccine: Novartis IndiaEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Novartis India said there was no shortage of rabies vaccine in the country, despite manufacturing constraints at Ankaleswar plant of Chiron Behring Vaccines.
Source: The Economic Times Healthcare and Biotech News - October 27, 2009 Category: Pharmaceuticals Source Type: news
Lieberman Opposes Health BillEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Sen. Joe Lieberman said he would vote to block passage of Senate health-care language in its current form, dealing a setback to efforts to gather 60 votes for the bill.
Source: WSJ.com: Health - October 27, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Schwarzenegger Urges Health ReformEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
California's Schwarzenegger urged lawmakers in a letter to pass a health-care package by the end of the year, while saying he opposed some elements of the current proposal.
Source: WSJ.com: Health - October 27, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Integra LifeSciences Featured in Forbes 2009 List of 200 Best Small CompaniesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
PLAINSBORO, N.J., Oct. 27, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a world leader in regenerative medicine, announced today that it has made Forbes magazine's 2009 list of "200 Best Small Companies."
Source: Medical News (via PRIMEZONE) - October 27, 2009 Category: Pharmaceuticals Source Type: news
FDA Approves Glaxo Leukemia DrugEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The Food and Drug Administration approved Arzerra, a leukemia treatment that will be marketed by GlaxoSmithKline for patients who have failed to respond to other therapies.
Source: WSJ.com: Health - October 27, 2009 Category: Pharmaceuticals Tags: PAID Source Type: news
Republicans Target AARP Insurance TiesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Republicans in Congress are taking aim at AARP's financial ties to the health-insurance industry just as the advocacy group is taking a more prominent role supporting an overhaul of the nation's health-care system.
Source: WSJ.com: Health - October 27, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Competitive Technologies Announces Outlook for Fiscal 2010 and Financial Results for Fiscal 2009Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
FAIRFIELD, Conn., Oct. 27, 2009 (GLOBE NEWSWIRE) -- Competitive Technologies, Inc. (NYSE Amex:CTT) today announced its outlook for fiscal 2010, and financial results for the fiscal fourth quarter and full year ended July 31, 2009.
Source: Medical News (via PRIMEZONE) - October 27, 2009 Category: Pharmaceuticals Source Type: news
Zydus maintains growth with 39% rise in netEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
ZYDUS Cadila maintained its growth pace by posting 39% jump in its net profit for the second quarter ended September 30, a figure identical to that posted in the first quarter of this fiscal. The Rs 3,000-crore Ahmedabad-based pharma major launched 31 products in the first half of the financial year.
Source: The Economic Times Healthcare and Biotech News - October 27, 2009 Category: Pharmaceuticals Source Type: news
Reid Says Bill Will Have Public PlanEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The Senate majority leader said the health-care bill he is bringing to the floor will include a government-run health-insurance plan.
Source: WSJ.com: Health - October 27, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
U.S. Needs More Health Preparedness for Climate ChangeEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Climate change will mean new health problems for the United States, but public health officials play only a limited role in decisions about how to cope with the changing environment, a report said on Monday. Reuters Health Information
Source: Medscape Business of Medicine Headlines - October 27, 2009 Category: Pharmaceuticals Tags: Business of Medicine Source Type: info
Lumenis Receives 510(k) Clearance for the PolyScope Disposable Flexible EndoscopeEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
SANTA CLARA, Calif., Oct. 27 (HSMN NewsFeed) -- Lumenis Ltd., a global developer, manufacturer and seller of laser, light-based and radiofrequency devices for surgical, aesthetic, and ophthalmic applications, announced that on September 30th, 2009 the FD... Devices, FDALumenis, PolyScope, Flexible Endoscope, endoscopy
Source: HSMN NewsFeed - October 27, 2009 Category: Pharmaceuticals Source Type: news
Icagen Reports Top-line Results of Phase IIa Study of Senicapoc in Exercise-Induced AsthmaEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
RESEARCH TRIANGLE PARK, N.C., Oct. 26,
2009 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today reported
that in a proof-of-concept, Phase IIa exercise-induced asthma
study, senicapoc failed to demonstrate improvement in the primary
study...
Source: Drugs.com - Clinical Trials - October 27, 2009 Category: Pharmaceuticals Source Type: clinical trials
SenoRx Appoints John T. Buhler President and Chief Operating OfficerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
IRVINE, Calif., Oct. 27, 2009 --(HSMN NewsFeed) -- SenoRx, Inc. (Nasdaq:SENO ) today announced the appointment of John T. Buhler to the newly created position of President and Chief Operating Officer. Buhler, who currently serves as SenoRx's Senior Vice Pr... Devices, Oncology, PersonnelSenoRx, breast cancer
Source: HSMN NewsFeed - October 27, 2009 Category: Pharmaceuticals Source Type: news
Cephalon Appoints Bob Repella as Senior Vice President of U.S. Pharmaceutical OperationsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
FRAZER, Pa., Oct. 27 (HSMN NewsFeed) -- Cephalon, Inc. (Nasdaq: CEPH ) announced today that Bob Repella has joined as Senior Vice President, U.S Pharmaceutical Operations. In this role, Mr. Repella will have responsibility for managing all aspects of the... Biopharmaceuticals, PersonnelCephalon
Source: HSMN NewsFeed - October 27, 2009 Category: Pharmaceuticals Source Type: news
Onset Medical Performs First Human Use of the SoloPath Endovascular Access Catheter to Deliver Percutaneous Aortic Heart ValveEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
IRVINE, Calif.--(HSMN NewsFeed)--Onset Medical Corporation announced today the first human usage of its SoloPath(TM) Endovascular Access Catheter in a case performed by Eberhard Grube MD, Chief, Department of Cardiology/Angiology, Helios Heart Center, Sieg... Devices, Interventional CardiologyOnset Medical, SoloPath, Endovascular Access Catheter, aortic valve
Source: HSMN NewsFeed - October 27, 2009 Category: Pharmaceuticals Source Type: news
Changing Behavior Helps Patients Take Medication as PrescribedEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
COLUMBIA, Mo., Oct. 26, 2009 – Taking medication as
the doctor prescribes is crucial to improving health. However, 26
to 59 percent of older adults do not adhere to instructions,
according to a 2003 study published in Drugs and Aging. In a...
Source: Drugs.com - Pharma News - October 27, 2009 Category: Pharmaceuticals Source Type: news
27.10.09: Renewed year-on-year growth in underlying EBITDA in the third quarter of 2009:Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Bayer back on the uptrend HealthCare again strong - weak quarter at CropScience - MaterialScience substantially improved / Group sales EUR 7,392 million (minus 7.0 percent) / EBITDA before special items EUR 1,499 million (plus 0.4 percent) / Net income EUR 249 million (minus 10.1 percent) / Net cash flow EUR 1,517 million (plus 22.9 percent) / Full-year Group forecast confirmedmehr ...
Source: Bayer IR Newsfeed: Events - October 27, 2009 Category: Pharmaceuticals Source Type: news
Revolutionary New Treatment for Sciatica Advances in the ClinicEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Chronic and severe sciatica causes widespread disability, and represents a significant unmet medical need. Localized administration of etanercept, a unique anti-inflammatory therapeutic, represents a revolutionary new approach for reducing nerve root inflammation. This off-label treatment method, invented by a Los Angeles physician, Edward Tobinick MD, has increasing scientific support, including new data from randomized, placebo-controlled studies. (PRWeb Oct 27, 2009)
Read the full story at http://www.prweb.com/releases/etanercept/sciatica/prweb3110944.htm
Source: PRWeb: Medical Pharmaceuticals - October 27, 2009 Category: Pharmaceuticals Source Type: news
Growing Threat of Substandard and Counterfeit Medicines in Developing Countries Addressed by New USAID-USP Cooperative AgreementEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
With substandard and counterfeit versions of medicines intended to treat life-threatening diseases such as malaria, HIV/AIDS and tuberculosis posing a growing threat throughout the developing world, the U.S. Agency for International Development (http://www.usaid.gov/) (USAID) and the U.S. Pharmacopeial Convention (http://www.usp.org/) (USP) will expand their joint efforts to combat this menace by launching a new program over the next five years. (PRWeb Oct 27, 2009)
Read the full story at http://www.prweb.com/releases/USAID/USP/prweb3113234.htm
Source: PRWeb: Medical Pharmaceuticals - October 27, 2009 Category: Pharmaceuticals Source Type: news
An Alternative To Adderall?Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
PROFIDERALL Becomes the First and Only 'Cognitive Energy Enhancer' Available Without a Prescription (PRWeb Oct 27, 2009)
Read the full story at http://www.prweb.com/releases/2009/10/prweb2828864.htm
Source: PRWeb: Medical Pharmaceuticals - October 27, 2009 Category: Pharmaceuticals Source Type: news
Fastrack Clients Realize Substantial Benefits from On-Line TrainingEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Fastrack Healthcare's On-Line Training (https://fastrack.webex.com/mw0305l/mywebex/default.do?siteurl=fastrack) for HME, DME, Infusion & Homecare Agency Available 24/7! (PRWeb Oct 27, 2009)
Read the full story at http://www.prweb.com/releases/online/training/prweb3111064.htm
Source: PRWeb: Medical Pharmaceuticals - October 27, 2009 Category: Pharmaceuticals Source Type: news
Spectrum Announces Proactive Approach to the Prevention of Melamine ContaminationEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Spectrum Chemicals & Laboratory Products announced it is fully committed to ensuring that every one of their products that contains, or is produced, using one of the pharmaceutical components identified by the U.S. FDA Center for Veterinary Medicine (CVM), a part of FDA's Center for Drug Evaluation and Research (CDER), is free from melamine contamination. Spectrum has developed a proactive approach to the prevention of melamine contamination by documenting the source of all raw materials utilized in the manufacturing process, the assessment of the manufacturing process itself, and the evaluation of other potential...
Source: PRWeb: Medical Pharmaceuticals - October 27, 2009 Category: Pharmaceuticals Source Type: news
Vestara Awarded MedAssets Supplier Contract For Automated Pharmaceutical Waste Management SolutionEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Vestara, provider of the industry's only automated pharmaceutical waste management solution, announced today that it has been awarded a MedAssets supplier contract. MedAssets serves more than 1,700 hospitals and health systems through its group purchasing organization (GPO). (PRWeb Oct 27, 2009)
Read the full story at http://www.prweb.com/releases/2009/10/prweb3114604.htm
Source: PRWeb: Medical Pharmaceuticals - October 27, 2009 Category: Pharmaceuticals Source Type: news
Patients who Participated in Pleio GoodStart™ Refilled 30% Sooner and 40% More, Averaging 2 Additional Rx Refills per PatientEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Patients who participated in Pleio (www.pleio.com) GoodStart™ refilled 30% sooner and 40% more, averaging 2 additional Rx refills per patient during first 9 months of therapy. (PRWeb Oct 26, 2009)
Read the full story at http://www.prweb.com/releases/Pleio/adherence_program/prweb3109834.htm
Source: PRWeb: Medical Pharmaceuticals - October 27, 2009 Category: Pharmaceuticals Source Type: news
